Vivos Therapeutics, Inc. (VVOS)
Market Closed
18 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 50
-0.01
-2.1526%
$
3.37M Market Cap
- P/E Ratio
- Div Yield
500,600 Volume
-3.4 Eps
$ 0.51
Previous Close 
Want to track VVOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vivos Therapeutics, Inc. (VVOS) Statistics
Valuation metrics
Market Cap 3.37M
Enterprise value 13.53M
Trailing P/E (ttm) -0.33
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 0.17
Price/Book (mrq) -7.36
Enterprise Value/Revenue 0.69
Enterprise Value/EBITDA -0.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 279.37K
Average volume (90 days) 256.06K
Price summary
52-Week low 0.45
52-Week high 7.95
Beta -
50-Day moving average 0.7
200-Day moving average 1.49
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 27 Oct 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.28%
Operating margin -1.15%
Operational effectiveness
Return on assets -1%
Return on equity -22.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.34
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.72
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.14
Total debt (mrq) -
Total Debt/Equity (mrq) -10.78
Current ratio (mrq) 0.27%
Book value per share (mrq) -0.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
